Vinblastine sulfate
CAS No. 143-67-9
Vinblastine sulfate ( 29060LE; Alkaban-AQ; Exal; NSC 49842; Rozevinsulfate; Velban; Velsar )
Catalog No. M11857 CAS No. 143-67-9
Vinblastine sulfate can inhibit the formation of microtubule, it also inhibit nAChR(IC50=8.9 uM).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
10MG | 49 | In Stock |
|
25MG | 58 | In Stock |
|
50MG | 76 | In Stock |
|
100MG | 87 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVinblastine sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionVinblastine sulfate can inhibit the formation of microtubule, it also inhibit nAChR(IC50=8.9 uM).
-
DescriptionVinblastine sulfate can inhibit the formation of microtubule, it also inhibit nAChR(IC50=8.9 uM).
-
Synonyms29060LE; Alkaban-AQ; Exal; NSC 49842; Rozevinsulfate; Velban; Velsar
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptornAChR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number143-67-9
-
Formula Weight909.06
-
Molecular FormulaC46H58N4O9·H2SO4
-
Purity>98%(HPLC)
-
SolubilitySoluble in DMSO
-
SMILESCC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gigant B, et al. Nature, 2005, 435(7041), 519-522.
molnova catalog
related products
-
Benzetimide hydrochl...
Benzetimide hydrochloride is an antagonist of muscarinic acetylcholine receptor.treatment neuroleptic-induced parkinsonism.?
-
PNU 282987
PNU-282987 is a selective α7 nicotinic acetylcholine receptor(α7 nAChR) agonist with Ki of 26 nM; no affinity for α1β1γδ and α3β4 nAChRs (IC50 ≥ 60 μM).
-
α-Conotoxin AuIB
Selective antagonist of α3β4 nicotinic acetylcholine receptors. Displays > 100-fold selectivity over other receptor subunit combinations including α2β2, α2β4, α3β2, α4β2, α4β4 and α1β1γδ.